MicroRNA expression profiles for the NCI-60 cancer cell panel
暂无分享,去创建一个
John N Weinstein | Wolfgang Sadee | Philip L Lorenzi | Joseph S Verducci | Eric P Kaldjian | Paul E Blower | J. Weinstein | W. Reinhold | J. Verducci | C. Croce | P. Blower | W. Sadee | Shili Lin | E. Kaldjian | Z. Dai | P. Lorenzi | Changfeng Liu | Carlo M Croce | Chang-Gong Liu | William Reinhold | Ji-Hyun Chung | Shili Lin | Zunyan Dai | Jin Zhou | Jihyun Chung | Jin Zhou | Zunyan Dai
[1] J. Weinstein,et al. Karyotypic complexity of the NCI-60 drug-screening panel. , 2003, Cancer research.
[2] G. S. Johnson,et al. An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.
[3] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[4] J N Weinstein,et al. A protein expression database for the molecular pharmacology of cancer , 1997, Electrophoresis.
[5] C. Croce,et al. MicroRNA-cancer connection: the beginning of a new tale. , 2006, Cancer research.
[6] J. Weinstein,et al. Karyotypic "state" as a potential determinant for anticancer drug discovery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[7] M. Boyd,et al. Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen , 1995 .
[8] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] C. Barbacioru,et al. Correlating gene expression with chemical scaffolds of cytotoxic agents: ellipticines as substrates and inhibitors of MDR1 , 2005, The Pharmacogenomics Journal.
[10] C. Croce,et al. MicroRNAs and chromosomal abnormalities in cancer cells , 2006, Oncogene.
[11] Tushar Patel,et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. , 2006, Gastroenterology.
[12] J. Mesirov,et al. Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] Richard Lugg,et al. Mutation analysis of 24 known cancer genes in the NCI-60 cell line set , 2006, Molecular Cancer Therapeutics.
[14] J. Weinstein,et al. Transcriptomic analysis of the NCI-60 cancer cell lines. , 2003, Comptes rendus biologies.
[15] Gabriel S. Eichler,et al. Asparagine synthetase as a causal, predictive biomarker for l-asparaginase activity in ovarian cancer cells , 2006, Molecular Cancer Therapeutics.
[16] M. Jovanović,et al. miRNAs and apoptosis: RNAs to die for , 2006, Oncogene.
[17] John N Weinstein,et al. Integromic analysis of the NCI-60 cancer cell lines. , 2004, Breast disease.
[18] William C Reinhold,et al. Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel , 2006, Molecular Cancer Therapeutics.
[19] William C Reinhold,et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] David J. Groggel,et al. Practical Nonparametric Statistics , 2000, Technometrics.
[21] Shuomin Zhu,et al. miR-21-mediated tumor growth , 2007, Oncogene.
[22] John N. Weinstein,et al. Spotlight on molecular profiling: “Integromic” analysis of the NCI-60 cancer cell lines , 2006, Molecular Cancer Therapeutics.
[23] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Weinstein. 'Omic' and hypothesis-driven research in the molecular pharmacology of cancer. , 2002, Current opinion in pharmacology.
[25] Christian A. Rees,et al. Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.
[26] Ying Huang,et al. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. , 2005, Cancer research.
[27] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] William C Reinhold,et al. Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. , 2003, Cancer research.
[29] G. Hutvagner,et al. Principles and effects of microRNA-mediated post-transcriptional gene regulation , 2006, Oncogene.
[30] Jason H. Moore,et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. , 2007, Cancer research.
[31] C. Croce,et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Weinstein,et al. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data , 2002, The Pharmacogenomics Journal.
[33] Ruili Huang,et al. Linking tumor cell cytotoxicity to mechanism of drug action: An integrated analysis of gene expression, small‐molecule screening and structural databases , 2005, Proteins.
[34] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[35] Ying Huang,et al. Prediction of Anticancer Drug Potency from Expression of Genes Involved in Growth Factor Signaling , 2006, Pharmaceutical Research.
[36] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[37] Sergio Contrino,et al. The ArrayExpress gene expression database: a software engineering and implementation perspective , 2005, Bioinform..
[38] Jae K. Lee,et al. Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study , 2007, Molecular Cancer Therapeutics.
[39] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.
[40] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.
[41] J. Castle,et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.
[42] Anders Wallqvist,et al. Linking the growth inhibition response from the National Cancer Institute's anticancer screen to gene expression levels and other molecular target data , 2003, Bioinform..
[43] A. Hatzigeorgiou,et al. TarBase: A comprehensive database of experimentally supported animal microRNA targets. , 2005, RNA.
[44] Ruili Huang,et al. Drugs aimed at targeting characteristic karyotypic phenotypes of cancer cells , 2005, Molecular Cancer Therapeutics.
[45] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[46] Ali S. Hadi,et al. Finding Groups in Data: An Introduction to Chster Analysis , 1991 .
[47] O. Kent,et al. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes , 2006, Oncogene.